Search

Roche Patents Blood Glucose Prediction System for Adverse Range Determination

The European Patent Office published patent application EP3651164A1, filed by Roche Diabetes Care GmbH, F. Hoffmann-La Roche AG, and mySugr GmbH. The patent covers methods and systems for determining the probability of a patient's blood glucose value falling within an adverse range at a specified prediction time. The patent is classified under G16H 50/20, 50/30, and 50/70 for health informatics diagnostics.